ruxolitinib | Ruxolitinib

Keyword	CPC	PCC	Volume	Score	Length of keyword
ruxolitinib	1.32	0.1	5686	49	11

Keyword	CPC	PCC	Volume	Score
ruxolitinib	1.28	0.4	9747	10
ruxolitinib cream	0.03	0.1	4647	73
ruxolitinib phosphate	0.5	0.1	6536	18
ruxolitinib vitiligo	0.78	1	2334	86
ruxolitinib topical	1.37	0.3	2393	72
ruxolitinib package insert	1.74	0.1	2570	68
ruxolitinib jakafi	1.39	0.2	2933	66
ruxolitinib side effects	0.28	0.7	2842	69
ruxolitinib moa	0.88	0.2	7635	15
ruxolitinib brand name	0.18	0.8	3963	15
ruxolitinib cost	0.43	0.1	6940	20
ruxolitinib mechanism of action	0.11	0.1	5241	78
ruxolitinibe	0.17	0.3	6767	53
ruxolitinib cream vitiligo	0.61	0.4	3994	44
ruxolitinib cream price	1.57	0.2	2248	86
ruxolitinib tablets	1.4	0.7	4419	93
ruxolitinib ema	1.42	0.4	2758	16
ruxolitinib pronunciation	0.37	0.4	2405	16
ruxolitinib jakavi	1.11	0.7	2174	54
ruxolitinib precio	0.17	1	19	39
ruxolitinib prescribing information	0.04	0.7	2282	38
ruxolitinib vs hydroxyurea	0.3	0.4	2536	71
ruxolitinib cream fda approval	0.31	0.3	4059	89
ruxolitinib crema	0.68	0.8	1597	100

Search Results related to ruxolitinib on Search Engine

Ruxolitinib - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Ruxolitinib

WEBRuxolitinib, sold under the brand name Jakafi among others, is a medication used for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative neoplasm that affects the bone marrow; polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; and steroid-refractory acute graft ...

DA: 45 PA: 72 MOZ Rank: 12

Ruxolitinib Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/ruxolitinib.html

WEBMar 2, 2023 · Ruxolitinib is used in adults to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that affect your body's ability to produce blood cells. Ruxolitinib is also used to treat graft versus host disease in adults and children at …

DA: 6 PA: 10 MOZ Rank: 62

Ruxolitinib (Oral Route) Description and Brand Names - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/drugs-supplements/ruxolitinib-oral-route/description/drg-20075326

WEBApr 1, 2024 · Ruxolitinib is used to treat intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. Myelofibrosis is a life-threatening bone marrow problem which is manifested by the following symptoms: enlarged spleen (splenomegaly), severe …

DA: 11 PA: 60 MOZ Rank: 94

Ruxolitinib - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK570600/

WEBJun 5, 2023 · Continuing Education Activity. Ruxolitinib is a medication used to manage and treat myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease. It is in the Janus Kinase inhibitor class of medications. This activity reviews the indications, action, and contraindications for ruxolitinib as a valuable agent in ...

DA: 73 PA: 81 MOZ Rank: 24

Jakafi® (ruxolitinib) Prescription Medicine
jakafi.com

https://www.jakafi.com/

WEBLearn about Jakafi® (ruxolitinib) – Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, and adults with certain types of myelofibrosis.

DA: 91 PA: 77 MOZ Rank: 96

Ruxolitinib: MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a612006.html

WEBRuxolitinib is used to treat myelofibrosis (a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). It is also used to treat polycythemia vera (PV; a slow growing cancer of the blood in which the bone marrow makes too many red blood cells) in people who were not able to be ...

DA: 15 PA: 21 MOZ Rank: 13

Ruxolitinib: Uses, Interactions, Mechanism of Action | DrugBank …
drugbank.com

https://go.drugbank.com/drugs/DB08877

WEBRuxolitinib is a kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.

DA: 32 PA: 63 MOZ Rank: 49

Jakafi: Uses, Dosage, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/jakafi.html

WEBSep 29, 2023 · Generic name: ruxolitinib [ RUX-oh-LI-ti-nib ] Drug class: Multikinase inhibitors. Medically reviewed by Judith Stewart, BPharm. Last updated on Sep 29, 2023. Uses. Warnings. Before taking. Dosage. Side effects. Interactions. FAQ. What is Jakafi? Jakafi is used to treat certain types of myelofibrosis in adults.

DA: 53 PA: 32 MOZ Rank: 21

ruxolitinib oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-158425/ruxolitinib-oral/details

WEBGeneric Name: ruxolitinib. This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera ). It works by blocking your body from producing substances...

DA: 50 PA: 36 MOZ Rank: 67

Ten years of treatment with ruxolitinib for myelofibrosis: a review …
biomedcentral.com

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01471-z

WEBJul 27, 2023 · Ruxolitinib is an oral Janus kinase (JAK) 1/JAK2 inhibitor first approved by the US Food and Drug Administration (FDA) in 2011 for the treatment of adults with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera (PV) MF, and post-essential thrombocythemia MF (Fig. 1) [ 1 ].

DA: 24 PA: 73 MOZ Rank: 59